Passion for science does NOT have to look like:.▪️Being in the lab 24/7.▪️Publishing countless papers.▪️A high title in #academia. Passion for science can simply be:.✅'I think that thing is really cool, and I'm excited to learn more about it!'. #AcademicTwitter @AcademicChatter.

RT @pdhsu: And learn more via this excellent article from @GENbio by @xiaofei_lin, with excellent quotes from many top scientists in the co….

As a baseline, competitors will initially go head-to-head with Arc’s first virtual cell model, STATE, which is designed to predict how various stem cells, cancer cells, and immune cells respond to drugs, cytokines, or genetic perturbations. 3/3.

The initiative is a step toward virtual cell benchmarking, and follows in the footsteps of the CASP competition, the biannual experiment that assesses the latest state-of-the-art models in protein structure prediction, which enabled Nobel Prize-winning, AlphaFold. 2/.

.@arcinstitute has announced the inaugural “Virtual Cell Challenge,” sponsored by @nvidia,.@10xGenomics, and @UltimaGenomics, which will evaluate the ability of AI models to generalize to new cell contexts for therapeutic applications. 1/.

.@Xaira_Thera has released the largest publicly available Perturb-seq dataset to train the AI-powered virtual cell for drug discovery! . The work is described in Xaira's first preprint, capping a year after the company's $1 billion launch.

@GENbio With insights from @SurgeBiswas @nablabio, Robert Ragotte @UWproteindesign, @SeanRMcClain, Amaro Taylor-Weiner @abscibio, @ggrigoryanv, Alex Snyder @generate_biomed, and @thisismadani @ProfluentBio.

AI hype or reality - can we design antibodies from scratch?. In my latest article for @GENbio, I unpack how arguments over terminology have clouded the industry’s shared mission of bringing better therapeutics to the clinic faster.

RT @IMPRINTlabs: 📣Major thanks to @xiaofei_lin at @GENbio for this lovely piece on IMPRINT! It was a pleasure for our founders — @BeckBrach….

RT @GENbio: ASGCT 2025: World’s First Patient Treated with Personalized CRISPR Therapy .— @xiaofei_lin reports on the breaking news from @k….

BREAKING NEWS: World’s first patient treated with personalized CRISPR therapy. Born with a severe metabolic disease, an infant has improved after receiving an individualized gene editing therapy, a glimpse of a new era in genomic precision medicine.

RT @AlexWestchester: 26April: Hear about #biotech job cuts, @Roche’s US #Manufacturing plans, #DNADay & how far the #DNA field has come fro….

RT @GENbio: Machine Learning Engineers Bespoke Cas9 Enzymes for Gene Editing. Read more of what @BKleinstiver and @RachelSilvers11 from HMS….

Check out @pdhsu's thread for a deep dive into the preprint:.

In the collaboration with @arcinstitute and @nvidia, Evo 2 sizes up at 40 billion parameters and is trained on more than 9.3 trillion nucleotides from the genomes of more than 128,000 species across the tree of life.

Evo 2 is here!. Claiming to be "the largest publicly available #AI model for biology to date," Evo 2 now includes info from humans, plants, and more eukaryotic species to expand its capabilities in generative functional genomics. @pdhsu @BrianHie @GENbio.

Leveraging protein structure prediction tools, researchers from @TheLeonardLab @NorthwesternU present an #AI based framework to uncover potential structural design rules across receptor families for improved cell therapies. Read more at @GENbio: .

RT @RecursionPharma: Hear from Chief R&D and Chief Commercial Officer Najat Khan, PhD this Wed., Oct. 30, 8:10am PT/11:10am ET when she giv….

RT @KevinADavies: Wow! 3,500 registrants and counting for “The State of AI in Drug Discovery” @GENbio virtual event next Wednesday, headlin….

RT @AlexWestchester: 23October: Proud to join @xiaofei_lin and @GENbio colleagues at our upcoming virtual summit "The State of AI in Drug D….

RT @generate_biomed: @ggrigoryanv, our CTO and co-founder, will be speaking at @GENbio's State of AI in Drug Discovery 2024 virtual summit….